Phreesia, Inc. $PHR Shares Sold by Whetstone Capital Advisors LLC

Whetstone Capital Advisors LLC cut its position in shares of Phreesia, Inc. (NYSE:PHR) by 34.0% during the second quarter, Holdings Channel.com reports. The firm owned 629,752 shares of the company’s stock after selling 324,176 shares during the quarter. Phreesia makes up approximately 1.7% of Whetstone Capital Advisors LLC’s portfolio, making the stock its 16th biggest position. Whetstone Capital Advisors LLC’s holdings in Phreesia were worth $6,480,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently bought and sold shares of PHR. Pale Fire Capital SE purchased a new stake in shares of Phreesia in the 1st quarter valued at approximately $72,481,000. BlackRock Inc. acquired a new position in Phreesia in the second quarter valued at approximately $72,234,000. Granahan Investment Management LLC grew its position in Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after acquiring an additional 1,018,987 shares during the period. Prosight Management LP purchased a new position in Phreesia in the fourth quarter worth approximately $16,533,000. Finally, Millennium Management LLC increased its stake in Phreesia by 730.7% during the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after acquiring an additional 936,033 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Trading Up 1.3%

Shares of NYSE PHR opened at $10.35 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $642.55 million, a PE ratio of 60.90 and a beta of 0.86. Phreesia, Inc. has a twelve month low of $7.77 and a twelve month high of $27.00. The stock has a fifty day simple moving average of $11.26 and a 200-day simple moving average of $10.43.

Phreesia (NYSE:PHR) last announced its earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The firm had revenue of $129.46 million for the quarter, compared to analysts’ expectations of $129.06 million. Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.01 earnings per share. On average, equities analysts forecast that Phreesia, Inc. will post 0.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PHR has been the subject of a number of recent analyst reports. Truist Financial raised their price objective on Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a research report on Thursday, May 28th. Weiss Ratings lowered shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, September 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $19.00 price target on shares of Phreesia in a research report on Thursday, September 3rd. Raymond James Financial downgraded shares of Phreesia from an “outperform” rating to a “market perform” rating in a research note on Tuesday. Finally, Needham & Company LLC restated a “buy” rating and issued a $14.00 price objective on shares of Phreesia in a report on Monday, August 31st. Eight research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Phreesia has an average rating of “Hold” and an average target price of $14.00.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.